Pluripotent therapeutic compositions and uses thereof

Abstract

Synthetic Stem Cell-like Tissue Healing and Regeneration Medication with Anti-inflammatory, Protein Synthesis, Enzyme Deficiency Activation and Genetic Therapy, and Anti-cancer Agent derived from a series of inventions that include these products of Biomolecular Engineering, Drug Discovery from a Biologic Periodic Table of Applied Biochemistry and Biophysics. Tissue has a self healing effect promoting tissue healing and tissue regeneration. Not only does it maintain good health but also it has been observed that the patient's blood is withdrawn from the patient and applied to the ulcer has healing qualities. Cartilage placed in a wound promotes and accelerates wound healing. The anabolic biochemical and biophysical equivalent of tissue has been found in these embodiments to have the same pharmacologic qualities, when devoid of genetic DNA mismatch and other catabolic factors including the catabolic effects of microorganism overgrowth that lacks pro-biotic qualities. The healing efficacy of these tissue components gives us further appreciation of the protective action of human tissue over and above and other than the immune protective system or perhaps an integral component part of the immune system.

1 . An composition comprising:
 a) at least one glycosaminoglycan, proteoglycan aggregate complex of hyaluronic acid, extracellular matrix, protein and chondroitin, extracellular matrix compound in an amount effective in the damaged tissue as an anti-neo-inflammatory and anti-neo-angiogenetic agent;   b) about one to three grams of at least one polar surface active lipid selected from the group consisting of phosphatidic acid, phophatidylethanolamine, lecithin, phosphatidylserine, phosphatidylinositol, 2-lysolecithin, plamalogen, choline plasmalogen, phostidyiglycerol, diphosphatidylglycerol, sphingomyelin, and any combination of 2, 3, 4, 5, 6, 7, 8, 9, 10, or 11 of said polar active surface lipids;   c) a plurality of enantiomerically pure L-amino acids and glycine of about 9 to 25 grams in molar ratios of human tissue;   d) a component selected from the group consisting of Polyoxyethylene Sorbitan Monooleate (TWEEN 80), Sorbitan monooleate (SPAN 80), grape seed extract, grape extract, and combinations thereof; and   e) vitamins, minerals or trace elements selected from the group consisting of Vitamin B12, Vitamin E, selenium, zinc, and combinations thereof.   
     
     
         2 . The composition of  claim 1 , further comprising one or more compound(s) generally accepted as safe (GRAS) selected from the group consisting of aspartame perfluorocarbon resins, perfluorocarbon cured elastomers, [alpha]-Amylase enzyme preparation from  Bacillus stearothermophilus , benzoic acid, bromelain, catalase (bovine liver), lactic acid, linoleic acid, potassium acid tartrate, propionic acid, stearic acid, tartaric acid, diacetyl tartaric acid esters of mono- and diglycerides, ammonium bicarbonate, ammonium carbonate, ammonium chloride, ammonium hydroxide, ammonium citrate, dibasic, ammonium phosphate, monobasic; ammonium phosphate, dibasic; bacterially-derived carbohydrase enzyme preparation; bacterially-derived protease enzyme preparation; bentonite; benzoyl peroxide; n-Butane and iso-butane; Calcium glycerophosphate; Calcium lactate; Calcium pantothenate; Calcium propionate; Calcium stearate; Carbon dioxide; Beta-carotene; Cellulase enzyme preparation derived from  Trichoderma longibrachiatum ; Clove and its derivatives; Cocoa butter substitute; Copper gluconate; Copper sulfate; L-Cysteine; L-Cysteine monohydrochloride; Dextrin; Diacetyl; Enzyme-modified fats; Ethyl alcohol; Ficin; Glucono delta-lactone; Corn gluten; Wheat gluten; Glyceryl monooleate; Glyceryl behenate; Glyceryl palmitostearate; Helium; Inositol; Insoluble glucose isomerase enzyme preparations; Isopropyl citrate; Animal lipase; Magnesium carbonate; Magnesium chloride; Magnesium hydroxide; Magnesium oxide; Magnesium phosphate; Magnesium stearate; Magnesium sulfate; Malt; Malt syrup (malt extract); Manganese chloride; Manganese citrate; Manganese gluconate; Manganese sulfate; Microparticulated protein product; Mono- and diglycerides; Monosodium phosphate derivatives of mono- and diglycerides; Niacin; Niacinamide; Nickel; Nitrogen; Nitrous oxide; Peptones; Pancreatin; Papain; Pectins; Pepsin; Potassium bicarbonate; Potassium carbonate; Potassium chloride; Potassium hydroxide; Potassium lactate; Propane; Pyridoxine hydrochloride; Rennet (animal-derived) and chymosin preparation (fernentation-derived); Riboflavin; Riboflavin-5′-phosphate (sodium); Sodium benzoate; Sodium carbonate; Sodium hydroxide; Sodium hypophosphite; Sodium lactate; Sodium metasilicate; Sodium propionate; Sodium sesquicarbonate; Sodium tartrate; Sodium potassium tartrate; Starter distillate; Stearyl citrate; Thiamine hydrochloride; Thiamine mononitrate; [alpha]-Tocopherols; Triacetin; Tributyrin; Triethyl citrate; Trypsin; Urease enzyme preparation from  Lactobacillus fermentum ; Vitamin A; Vitamin B12; Candelilla wax; Carnauba wax; Bakers yeast extract; Zein; Sulfamic acid; Clay (kaolin); Ferric oxide; Iron oxides; Japan wax; Tall oil: Alfalfa; Allspice; Almond, bitter (free from prussic acid); Ambrette; Angelica root; Angelica seed or stem; Angostura; Anise; Asafetida; Balm; Balsam of Peru; Basil; Bay leaves; Bay; Bergamot (bergamot orange); Bois de rose; Cacao; Camomile (chamomile);  Capsicum ; Caraway; Cardamom seed (cardamon); Carob bean; Carrot; Cascarilla bark;  Cassia  bark, Chinese;  Cassia  bark. Padang or Batavia;  Cassia  bark, Saigon; Celery seed; Cherry, wild, bark; Chervil; Chicory; Cinnamon bark, Ceylon; Cinnamon bark, Chinese; Cinnamon bark, Saigon; Cinnamon leaf, Ceylon; Cinnamon leaf. Chinese; Cinnamon leaf, Saigon; Citronella; Citrus peels; Clary (clary sage); Clove bud; Clove leaf; Clove stem; Clover; Coca; Coffee; Cola nut; Coriander; Corn silk; Cumin (cummin); Curacao orange peel; Cusparia bark; Dandelion; Dandelion root; Dill; Dog grass (quackgrass,  triticum ); Elder flowers; Estragole; Estragon (tarragon); Fennel, sweet; Fenugreek; Galanga (galangal); Garlic; Geranium; Geranium, East IndianGeranium, rose; Ginger; Glycyrrhiza; Glycyrrhizin, ammoniated; Grapefruit; Guava; Hickory bark; Horehound (hoarbound); Hops; Horsemint; Hyssop; Immortelle; Jasmine; Juniper (berries); Kola nut; Laurel berries; Laurel leaves; Lavender; Lavender, spike; Lavandin; Lemon; Lemon balm (see balm).; Lemon grass; Lemon peel; Licorice; Lime; Linden flowers; Locust beanLupulin; Mace; Malt (extract); Mandarin; Marjoram, sweet; Mate 1; Menthol; Menthyl acetate; Molasses (extract); Mustard; Naringin; Neroli, bigarade; Nutmeg; Onion; Orange, bitter, flowers; Orange, bitter, peel; Orange leaf; Orange, sweet; Orange, sweet, flowers; Orange, sweet, peel;  Origanum ; Palmarosa; Paprika; Parsley; Pepper, black; Pepper, white; PeppermintPeruvian balsam; Petitgrain; Petitgrain lemon; Petitgrain mandarin or tangerine; Pimenta; Pimenta leaf; Pipsissewa leaves; Pomegranate; Prickly ash bark; Rose absolute; Rosa; Rose; Rose buds; Rose flowers; Rose fruit (hips); Rose geranium; Rose leaves; Rosemary; Rue; Saffron; Sage; St. John's bread; Savory, summer; Savory, winter; Schinus molle; Sloe berries; Spearmint; Spike lavender; Tamarind; Tangerine; Tannic acid; Tarragon; Tea; Thyme; Triticum; Tuberose; Turmeric; Vanilla; Violet flowers; Violet leaves; Violet leaves absolute; Wild cherry bark; Ylang-ylang; and; Zedoary bark, or any combination of said compounds. 
     
     
         3 . The composition of  claim 1 , further comprising a flavorant. 
     
     
         4 . The composition of  claim 3 , wherein said flavorant is a fruit juice. 
     
     
         5 . The composition of  claim 4 , wherein said fruit juice is tomato juice. 
     
     
         6 . The composition of  claim 1 , wherein said amino acids are L-Leucine, L-Proline, L-Arginine, L-Valine, L-Aspartic Acid, L-Isoleucine, Glycine, L-Threonine, L-Tyrosine, L-Phenylalanine, L-Serine, L-Histidine, L-Alanine, L-Cystine, L-Tryptophan, L-Methionine, L-Glutamine, L-Glutamic Acid. L-Taurine, and L-Carnitine. 
     
     
         7 . The composition of  claim 1 , wherein said component (c) comprises Corn Syrup Solids, High Oleic Safflower Oil, Refined Vegetable Oil, L-Lysine L-Glutamate, Calcium Phosphate Dibasic, and less than 2% (by weight) of each of the following: L-Leucine, Tripotassium Citrate, L-Proline, L-Arginine, L-Valine, L-Aspartic Acid, L-Isoleucine, Glycine, L-Threonine, L-Tyrosine, L-Phenylalanine, L-Serine, L-Histidine, L-Alanine, Mono and Diglycerides, Sodium Chloride, L-Cystine, L-Tryptophan, Magnesium Acetate, L-Methionine, Potassium Chloride, Diacetyl Tartaric Acid Esters of Monoglycerides, L-Glutamine, Choline Bitartrate, L-Glutamic Acid, M-Inositol, L-Ascorbic Acid, Soy Lecithin, Tricalcium Phosphate, Ferrous Sulfate, Zinc Sulfate, L-Carnitine, Niacinamide, DL-alpha Tocopheryl Acetate, Calcium D-Pantothenate, Cupric Sulfate, Manganese Sulfate, Pyridoxine Hydrochloride, Vitamin A Acetate, Riboflavin, Thiamine Chloride Hydrochloride, Potassium Iodide, Chromium Sulfate, Phylloquinone, Sodium Molybdate, Folic Acid, Sodium Hydrogen Selenite, D-Biotin, Vitamin D 3  and Cyanocobalamin. 
     
     
         8 . The composition of  claim 7 , wherein said composition further comprises taurine. 
     
     
         9 . A method of treating Crohn's disease comprising the administration of a composition according to  claim 1  to an individual in an amount sufficient to alleviate symptoms associated with Crohn's disease. 
     
     
         10 . A method of reducing the amount of corticosteroid necessary for the treatment of Crohn's disease in an individual having Crohn's disease comprising the administration of a composition according to  claim 1  to said individual in an amount sufficient to reduce the amount of corticosteroid necessary to control the disease. 
     
     
         11 . An anabolic composition, comprising at least one amino acid, at least one extracellular matrix compound, and at least one surfactant, wherein the concentration of surfactant in the composition is about 1% or greater (w/w or w/v) with respect to the total composition. 
     
     
         12 . The anabolic composition of  claim 11 , wherein the at least one surfactant is a lipid. 
     
     
         13 . The anabolic composition of  claim 12 , wherein the lipid is a phospholipid or essential lipid. 
     
     
         14 . The anabolic composition of  claim 13 , wherein the lipid is selected from the group consisting of phosphatidylcholine; phosphatidylserine; phosphatidylinositol; phosphatidylethanolamine; phosphatidic acid; phosphatidyl glycerol sphingolipids; sphingomyelin; glycolipids; cerbrosides; gangliosides; cephalin; lipovitellin; glycosphingolipids; lipids containing linoleic or linolenic acids; EPA; DHA and combinations thereof. 
     
     
         15 . The anabolic composition of  claim 1 , wherein the at least one surfactant is selected from the group consisting of glycerol monostearate; diethylene glycol fatty acid ester; polyoxyethylene sorbitol beeswax derivative; diethylene glycol monolaurate; diethylene glycol fatty acid ester; polyoxyethylene dioleate; sorbitan monopalmitate; sorbitan monolaurate; tetraethylene glycol monostearate; tetraethylene glycol monooleate; polyoxypropylene mannitol dioleate; polyoxyethylene sorbitol lanolin oleate derivative; polyoxypropylene stearate; polyoxyethylene fatty acid; polyoxyethylene sorbitol beeswax derivative; polyoxyethylene sorbitan monostearate; polyoxyethylene sorbitan monooleate; polyoxyethylene oxypropylene oleate; polyoxyethylene cetyl ether; polyoxyethylene sorbitan tristearate; polyoxyethylene lauryl ether; tetraethylene glycol monolaurate; polyoxyethylene lauryl ether; polyoxyethylene sorbitan trioleate; hexaethylene glycol monostearate; polyoxyethylene esters of mixed fatty and resin acids; polyoxyethylene oxypropylene oleate; polyoxyethylene lanolin derivative; polyoxyethylene monostearate; polyoxyethylene monopalmitate; alkyl aryl sultanate; triethanolamine oleate; polyoxyethylene alkyl phenol; polyoxyethylene sorbitol lanolin derivative; polyoxyethylene alkyl aryl ether; polyoxyethylene castor oil; polyoxyethylene vegetable oil; polyoxyethylene oleyl ether; polyoxyethylene stearyl alcohol; polyoxyethylene oleyl alcohol; polyoxyethylene fatty alcohol; polyoxyethylene cetyl alcohol; polyoxyethylene glycol monopalmitate; polyoxyethylene sorbitan monopalmitate; polyoxyethylene oxypropylene stearate; sodium oleate; potassium oleate; N-cetyl-N-ethyl morpholinium; polyglycerol polyricinolate; polysorbate 80; polysorbate 65 and sodium lauryl sulfate. 
     
     
         16 . The anabolic composition of  claim 11 , wherein the at least one surfactant is selected from the group consisting of lipid, a phospholipid, a glycolipid, a monoglyceride, a diglyceride and a lipoprotein. 
     
     
         17 . The anabolic composition of  claim 11 , wherein the at least one surfactant is present in a concentration of between about 1.2% and about 20%. 
     
     
         18 . The anabolic composition of  claim 11 , wherein the at least one surfactant is present in a concentration selected from the group consisting of about 1.2%, about 1.3%, about 1.4%, about 1.5%, about 1.6%, about 1.7%, about 1.8%, about 1.9%, about 2%, about 3%, about 4%, about 5%, about 10% and about 15%. 
     
     
         19 . The anabolic composition of  claim 11 , wherein the extracellular matrix compound is selected from the group consisting of glucosamines, glycosaminoglycans, collagens, cartilage, chondroitin sulfates, hyaluronic acid, hyaluronan mucopolysccharides, glycoproteins, and proteoglycans. 
     
     
         20 . The anabolic composition of  claim 11 , further comprising at least one electrolyte, mineral, vitamin, trace element, or combinations thereof. 
     
     
         21 . The anabolic composition of  claim 11 , further comprising a probiotic. 
     
     
         22 . A method of treating a disease or condition in a subject, comprising: (1) providing a subject who has the disease or condition; (2) administering to the subject an effective amount of a composition comprising at least one surfactant, wherein the total concentration of surfactant in the composition is greater than 1% (w/w or w/v).